Nuvig Therapeutics Appoints Julie Smith Chief Executive Officer

Go back to Nuvig Therapeutics Appoints Julie Smith Chief Executive Officer
Exelixis, Inc. (NASDAQ: EXEL) Delayed: 54.08 +0.39 (0.73%)
Previous Close $53.69    52 Week High $17.00 
Open $53.74    52 Week Low $3.55 
Day High $54.68    P/E N/A 
Day Low $53.70    EPS $-1.33 
Volume 1,949,759       

(NASDAQ: STOK) Delayed: 32.29 +0.89 (2.83%)
Previous Close $31.40    52 Week High
Open $31.76    52 Week Low
Day High $32.77    P/E N/A 
Day Low $31.52    EPS
Volume 1,274,423